Implementation of a Multicenter Biobanking Collaboration for Next-Generation Sequencing-Based Biomarker Discovery Based on Fresh Frozen Pretreatment Tumor Tissue Biopsies.
暂无分享,去创建一个
S. Sleijfer | P. V. van Diest | E. Cuppen | J. Schellens | E. Voest | F. Weeber | R. D. de Knegt | R. Mathijssen | M. D. de Jonge | E. van Werkhoven | W. Veldhuis | G. Cirkel | C. G. Gadellaa-van Hooijdonk | M. Koudijs | S. Willems | M. M. van den Heuvel | N. Steeghs | S. Bins | Isaac J Numan | A. Bruggink | M. Langenberg | M. Lolkema
[1] M. Ratain,et al. Analysis of Impact of Post-Treatment Biopsies in Phase I Clinical Trials. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] S. Sleijfer,et al. Unsolicited findings of next-generation sequencing for tumor analysis within a Dutch consortium: clinical daily practice reconsidered , 2016, European Journal of Human Genetics.
[3] E. Winer,et al. Variation in the Attitudes of Medical Oncologists Toward Research Biopsies in Patients With Metastatic Breast Cancer. , 2015, The oncologist.
[4] Ash A. Alizadeh,et al. Toward understanding and exploiting tumor heterogeneity , 2015, Nature Medicine.
[5] D. Adams,et al. Intra- and inter-tumor heterogeneity in a vemurafenib-resistant melanoma patient and derived xenografts , 2015, EMBO molecular medicine.
[6] Ryan Hendricks,et al. The landscape of precision cancer medicine clinical trials in the United States. , 2015, Cancer treatment reviews.
[7] E. Cuppen,et al. Detailed imaging and genetic analysis reveal a secondary BRAFL505H resistance mutation and extensive intrapatient heterogeneity in metastatic BRAF mutant melanoma patients treated with vemurafenib , 2015, Pigment cell & melanoma research.
[8] N. McGranahan,et al. Biological and therapeutic impact of intratumor heterogeneity in cancer evolution. , 2015, Cancer cell.
[9] M. Hatt,et al. 18F-FDG PET Uptake Characterization Through Texture Analysis: Investigating the Complementary Nature of Heterogeneity and Functional Tumor Volume in a Multi–Cancer Site Patient Cohort , 2015, The Journal of Nuclear Medicine.
[10] J. Wolchok,et al. Genetic basis for clinical response to CTLA-4 blockade in melanoma. , 2014, The New England journal of medicine.
[11] Charles Laymon,et al. Quantifying Metabolic Heterogeneity in Head and Neck Tumors in Real Time: 2-DG Uptake Is Highest in Hypoxic Tumor Regions , 2014, PloS one.
[12] Anne-Mette K. Hein,et al. Next-Generation Sequencing of RNA and DNA Isolated from Paired Fresh-Frozen and Formalin-Fixed Paraffin-Embedded Samples of Human Cancer and Normal Tissue , 2014, PloS one.
[13] Benjamin Haibe-Kains,et al. Inconsistency in large pharmacogenomic studies , 2013, Nature.
[14] Benjamin J. Raphael,et al. Mutational landscape and significance across 12 major cancer types , 2013, Nature.
[15] Mauricio O. Carneiro,et al. From FastQ Data to High‐Confidence Variant Calls: The Genome Analysis Toolkit Best Practices Pipeline , 2013, Current protocols in bioinformatics.
[16] E. Boerwinkle,et al. dbNSFP v2.0: A Database of Human Non‐synonymous SNVs and Their Functional Predictions and Annotations , 2013, Human mutation.
[17] S. Pradervand,et al. Identification of Multiple Mechanisms of Resistance to Vemurafenib in a Patient with BRAFV600E-Mutated Cutaneous Melanoma Successfully Rechallenged after Progression , 2013, Clinical Cancer Research.
[18] E. Kohn,et al. Feasibility and safety of sequential research‐related tumor core biopsies in clinical trials , 2013, Cancer.
[19] Vincent Ferretti,et al. Feasibility of real time next generation sequencing of cancer genes linked to drug response: Results from a clinical trial , 2013, International journal of cancer.
[20] J. Kimmelman,et al. Publication and Reporting Conduct for Pharmacodynamic Analyses of Tumor Tissue in Early-Phase Oncology Trials , 2012, Clinical Cancer Research.
[21] Gabor T. Marth,et al. Haplotype-based variant detection from short-read sequencing , 2012, 1207.3907.
[22] Wendy S. W. Wong,et al. Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs , 2012, Bioinform..
[23] T. de Baère,et al. Sequential research-related biopsies in phase I trials: acceptance, feasibility and safety. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.
[24] Pablo Cingolani,et al. © 2012 Landes Bioscience. Do not distribute. , 2022 .
[25] P. A. Futreal,et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. , 2012, The New England journal of medicine.
[26] Christopher A. Miller,et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. , 2012, Genome research.
[27] P. V. van Diest,et al. Primary Colorectal Cancers and Their Subsequent Hepatic Metastases Are Genetically Different: Implications for Selection of Patients for Targeted Treatment , 2011, Clinical Cancer Research.
[28] E. Cuppen,et al. Multiplexed array-based and in-solution genomic enrichment for flexible and cost-effective targeted next-generation sequencing , 2011, Nature Protocols.
[29] M. Hicks,et al. Outcomes of research biopsies in phase I clinical trials: the MD anderson cancer center experience. , 2011, The oncologist.
[30] Lorenza Mittempergher,et al. Gene Expression Profiles from Formalin Fixed Paraffin Embedded Breast Cancer Tissue Are Largely Comparable to Fresh Frozen Matched Tissue , 2011, PloS one.
[31] M. DePristo,et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.
[32] K. Flaherty,et al. Inhibition of mutated, activated BRAF in metastatic melanoma. , 2010, The New England journal of medicine.
[33] J. Charboneau,et al. Incidence of bleeding after 15,181 percutaneous biopsies and the role of aspirin. , 2010, AJR. American journal of roentgenology.
[34] Richard Durbin,et al. Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .
[35] L. Schwartz,et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). , 2009, European journal of cancer.
[36] M. Picchio,et al. Intratumoral Spatial Distribution of Hypoxia and Angiogenesis Assessed by 18F-FAZA and 125I-Gluco-RGD Autoradiography , 2008, Journal of Nuclear Medicine.
[37] A. McGuire,et al. Research ethics and the challenge of whole-genome sequencing , 2008, Nature Reviews Genetics.
[38] A. Giorgio,et al. Complications After Interventional Sonography of Focal Liver Lesions , 2003, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.
[39] J. Haaga,et al. Sequential tumor biopsies in early phase clinical trials of anticancer agents for pharmacodynamic evaluation. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.